[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @RNAiAnalyst Dirk Haussecker Dirk Haussecker posts on X about $srpt, $alny, $arwr, $prme the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::409194010/interactions)  - X Week XXXXXX -XX% - X Month XXXXXXX +283% - X Months XXXXXXX -XX% - X Year XXXXXXXXX -XX% ### Mentions: XX [#](/creator/twitter::409194010/posts_active)  - X Month XX +154% - X Months XXX -XX% - X Year XXX -XXXX% ### Followers: XXXXXX [#](/creator/twitter::409194010/followers)  - X Week XXXXXX +0.30% - X Month XXXXXX +1.90% - X Months XXXXXX +3.10% - X Year XXXXXX +8.20% ### CreatorRank: XXXXXXX [#](/creator/twitter::409194010/influencer_rank)  ### Social Influence [#](/creator/twitter::409194010/influence) --- **Social category influence** [stocks](/list/stocks) #5817 [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% **Social topic influence** [$srpt](/topic/$srpt) #2, [$alny](/topic/$alny) #1, [$arwr](/topic/$arwr) #2, [$prme](/topic/$prme) 6.78%, [$apge](/topic/$apge) 6.78%, [$lly](/topic/$lly) 5.08%, [$qure](/topic/$qure) #1, [$mgx](/topic/$mgx) 5.08%, [$ions](/topic/$ions) 5.08%, [$verv](/topic/$verv) XXXX% **Top accounts mentioned or mentioned by** [@towiu2](/creator/undefined) [@geneinvesting](/creator/undefined) [@bambossie81](/creator/undefined) [@hall8jack](/creator/undefined) [@deusexdividend](/creator/undefined) [@masterlongevity](/creator/undefined) [@sanctuarybio](/creator/undefined) [@biotechch](/creator/undefined) [@jamesmclaw70633](/creator/undefined) [@drmakaryfdas](/creator/undefined) [@amaymd](/creator/undefined) [@profoak](/creator/undefined) [@wkissel](/creator/undefined) [@bowtiedbiotech](/creator/undefined) [@aasgardinvest](/creator/undefined) [@potus](/creator/undefined) [@francaole](/creator/undefined) [@behaviorfin](/creator/undefined) [@elonmusk](/creator/undefined) [@bionerd51](/creator/undefined) **Top assets mentioned** [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Arrowhead Research Corporation (ARWR)](/topic/$arwr) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [Eli Lilly and Company (LLY)](/topic/$lly) [Ionis Pharmaceuticals, Inc. Common Stock (IONS)](/topic/$ions) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Merck & Co., Inc. (MRK)](/topic/$mrk) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Pfizer, Inc. (PFE)](/topic/$pfe) [BEAM (BEAM)](/topic/$beam) [SuperRare (RARE)](/topic/$rare) [Novartis AG (NVS)](/topic/$nvs) [Amgen, Inc. (AMGN)](/topic/$amgn) [Biogen Inc (BIIB)](/topic/$biib) [Dyne Therapeutics, Inc. Common Stock (DYN)](/topic/$dyn) [Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna) ### Top Social Posts [#](/creator/twitter::409194010/posts) --- Top posts by engagements in the last XX hours "$PRME $EDIT $SANA.3 #CRISPR names up XXX% on strong volume + in short order none of them have raised"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942683220497346864) 2025-07-08 20:32:27 UTC 19.5K followers, 11.8K engagements "@deusexdividend X years $VERV was about to start p2 in 2025. Phase 3s should then start in 2027. So likely X 1/2 years if safety deemed approriate for ASCVD population. $LLY"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944862132668895631) 2025-07-14 20:50:40 UTC 19.5K followers, XXX engagements "$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942960763590599039) 2025-07-09 14:55:19 UTC 19.5K followers, 3621 engagements "@Sanctuary_Bio Thanks for that I owe you. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945580253021147214) 2025-07-16 20:24:14 UTC 19.5K followers, 1115 engagements "Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942337968103940439) 2025-07-07 21:40:33 UTC 19.5K followers, 6307 engagements "Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945593959566188597) 2025-07-16 21:18:42 UTC 19.5K followers, 10.1K engagements "The $SRPT subQ SRP-1005 for #Huntington's does NOT target exon X transcript. Very unfortunate. When I did my Huntington's deep dive I came away w/ that this is a MUST. It can be done see $QURE and $ALNY. Stop wasting time develop exon X subQ. h/t @JamesMclaw70633"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945960507141206098) 2025-07-17 21:35:13 UTC 19.5K followers, 3248 engagements "$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945590783299457446) 2025-07-16 21:06:04 UTC 19.5K followers, 18.2K engagements "$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944679151429910692) 2025-07-14 08:43:34 UTC 19.5K followers, 5052 engagements "@GeneInvesting 'good day for gene therapy'.seriously $SRPT just dropped their gene therapy pipeline except for X LGMD type cause of PRV. :)"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945845469285880050) 2025-07-17 13:58:06 UTC 19.5K followers, XXX engagements "Hormone Replacement Therapy.one of @drmakaryFDA's favorite health interventions. Any playable stocks in that regard"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944867556470481038) 2025-07-14 21:12:14 UTC 19.5K followers, 5068 engagements "I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945911746549498014) 2025-07-17 18:21:28 UTC 19.5K followers, 2217 engagements "$ARWR bought some after-hours for giggles. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945579848560218124) 2025-07-16 20:22:37 UTC 19.5K followers, 2959 engagements "$apge priced for perfection or near that with $2.8B market cap on eve of critical atopic derm read-out. Science risk seems low but then again why are they first in category Also pin action on $nktr of interest"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942104658488565894) 2025-07-07 06:13:27 UTC 19.5K followers, 4978 engagements "I never considered $MREO because I didn't like their AATD program but $470M market cap and $60M in cash.what am I missing $RARE"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943049441805766901) 2025-07-09 20:47:41 UTC 19.5K followers, 5880 engagements "$MGX Old enough remember a time when investing in biotechs trading XX% below cash was viewed as irresponsible. .even partner $IONS didn't want the free cash an acquisition would have gotten them. 🚀🚀"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943011143338893526) 2025-07-09 18:15:30 UTC 19.5K followers, 3273 engagements "$apge: ' we are accelerating development plan by running another higher dose trial'. Mmh yep 'accelerating' by taking another year before arriving at p3 dose"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942195426494435471) 2025-07-07 12:14:08 UTC 19.5K followers, 4217 engagements "$srpt been traveling but aren't they due to report limb girdle data Too busy with salvaging Elevidys and keeping company liquid"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1940722085208486363) 2025-07-03 10:39:36 UTC 19.5K followers, 3484 engagements "@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942179396934062296) 2025-07-07 11:10:26 UTC 19.4K followers, XXX engagements "HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1944706566860439969) 2025-07-14 10:32:31 UTC 19.5K followers, 8715 engagements "$SRPT does restructuring largely take bankruptcy risk off table.assuming no more Elevidys safety surprises + exon skippers staying on market"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945749107621961976) 2025-07-17 07:35:12 UTC 19.5K followers, 2293 engagements "I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942338563875770722) 2025-07-07 21:42:55 UTC 19.5K followers, 2413 engagements "$mgx trading 2/3 below healthy cash balance. When will a shareholder go activist and ask them to slow-walk hemophilia program while looking for an alternative exit for its potentially lucrative small-sized CRISPR proteins. $IONS"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1940768650639847515) 2025-07-03 13:44:38 UTC 19.5K followers, 3732 engagements "$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943607302998597953) 2025-07-11 09:44:26 UTC 19.5K followers, 6338 engagements "A XX minute heads-up. Sounds serious. $SRPT"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945576893601706426) 2025-07-16 20:10:53 UTC 19.5K followers, 4653 engagements "@Franca_ole @BehaviorFin The big issue with essentially all large gene replacement tools is that they require DNA/AAV templates for delivery. $SGMO $PRME $MGX"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943615817934856553) 2025-07-11 10:18:16 UTC 19.5K followers, XXX engagements "$KALV oral on-demand pill for HAE approved by FDA $APGE anti-IL13 p2 hits in atopic dermatitis $JSPR CS Urticaria drug efficacious but manufacturing issues Quite the morning in the #dermatology space"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942209228522856750) 2025-07-07 13:08:59 UTC 19.5K followers, 5632 engagements "$srpt been out all day but -X% suggests it's kneejerk to $capr CRL and #FDA not believing in medicines for DMD"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1943728660491460659) 2025-07-11 17:46:40 UTC 19.5K followers, 4083 engagements "Get ready for some volatility as Trump gets ready to fire #Fed chair Powell. Ultimately would be very positive for #biotech. Could be a great buying op"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945512936191021521) 2025-07-16 15:56:44 UTC 19.5K followers, 2083 engagements "On the X hand #FDA said it wants to promote #wearables enabling people access to their health info👏. On the other hand it is now threatening to take action against a blood pressure wearable maker for not having it licensed as a medical device. wtf"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945747758729642252) 2025-07-17 07:29:50 UTC 19.5K followers, 1826 engagements "@GeneInvesting especially the impressive subQ data for CNS. platform. $srpt $arwr"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1945809743668252910) 2025-07-17 11:36:08 UTC 19.5K followers, XXX engagements "$APGE clearly efficacious though pbo response on high end. On safety XX% non-infective #conjunctivitis taking median of XX days to resolve. I'll trade that in for an ISR any day -- $NKTR"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942175248159219733) 2025-07-07 10:53:57 UTC 19.5K followers, 16.7K engagements "$KALV 50k on-demand treatments per year.pill option should grow usage say 60k EKTERLY stands out: oral rapid response clean safety -- only insurance will limit market share XX% market share-- $600M rev MC: $760M well financed Expect solid profits in '26 PT: $25"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942627017259635175) 2025-07-08 16:49:07 UTC 19.5K followers, 2432 engagements "Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1942914682471194785) 2025-07-09 11:52:12 UTC 19.5K followers, 2901 engagements "$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA"  [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1934948230745202794) 2025-06-17 12:16:22 UTC 19.5K followers, 2917 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@RNAiAnalyst Dirk Haussecker
Dirk Haussecker posts on X about $srpt, $alny, $arwr, $prme the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX -XX%
- X Month XXXXXXX +283%
- X Months XXXXXXX -XX%
- X Year XXXXXXXXX -XX%
Mentions: XX #
- X Month XX +154%
- X Months XXX -XX%
- X Year XXX -XXXX%
Followers: XXXXXX #
- X Week XXXXXX +0.30%
- X Month XXXXXX +1.90%
- X Months XXXXXX +3.10%
- X Year XXXXXX +8.20%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence stocks #5817 finance XXXX% cryptocurrencies XXXX%
Social topic influence $srpt #2, $alny #1, $arwr #2, $prme 6.78%, $apge 6.78%, $lly 5.08%, $qure #1, $mgx 5.08%, $ions 5.08%, $verv XXXX%
Top accounts mentioned or mentioned by @towiu2 @geneinvesting @bambossie81 @hall8jack @deusexdividend @masterlongevity @sanctuarybio @biotechch @jamesmclaw70633 @drmakaryfdas @amaymd @profoak @wkissel @bowtiedbiotech @aasgardinvest @potus @francaole @behaviorfin @elonmusk @bionerd51
Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Alnylam Pharmaceuticals, Inc. (ALNY) Arrowhead Research Corporation (ARWR) Apogee Therapeutics, Inc. Common Stock (APGE) Eli Lilly and Company (LLY) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Intellia Therapeutics, Inc (NTLA) Viking Therapeutics, Inc (VKTX) Merck & Co., Inc. (MRK) BridgeBio Pharma, Inc. Common Stock (BBIO) Pfizer, Inc. (PFE) BEAM (BEAM) SuperRare (RARE) Novartis AG (NVS) Amgen, Inc. (AMGN) Biogen Inc (BIIB) Dyne Therapeutics, Inc. Common Stock (DYN) Avidity Biosciences, Inc. Common Stock (RNA)
Top Social Posts #
Top posts by engagements in the last XX hours
"$PRME $EDIT $SANA.3 #CRISPR names up XXX% on strong volume + in short order none of them have raised"
@RNAiAnalyst on X 2025-07-08 20:32:27 UTC 19.5K followers, 11.8K engagements
"@deusexdividend X years $VERV was about to start p2 in 2025. Phase 3s should then start in 2027. So likely X 1/2 years if safety deemed approriate for ASCVD population. $LLY" @RNAiAnalyst on X 2025-07-14 20:50:40 UTC 19.5K followers, XXX engagements
"$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X" @RNAiAnalyst on X 2025-07-09 14:55:19 UTC 19.5K followers, 3621 engagements
"@Sanctuary_Bio Thanks for that I owe you. $SRPT" @RNAiAnalyst on X 2025-07-16 20:24:14 UTC 19.5K followers, 1115 engagements
"Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent" @RNAiAnalyst on X 2025-07-07 21:40:33 UTC 19.5K followers, 6307 engagements
"Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR" @RNAiAnalyst on X 2025-07-16 21:18:42 UTC 19.5K followers, 10.1K engagements
"The $SRPT subQ SRP-1005 for #Huntington's does NOT target exon X transcript. Very unfortunate. When I did my Huntington's deep dive I came away w/ that this is a MUST. It can be done see $QURE and $ALNY. Stop wasting time develop exon X subQ. h/t @JamesMclaw70633" @RNAiAnalyst on X 2025-07-17 21:35:13 UTC 19.5K followers, 3248 engagements
"$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY" @RNAiAnalyst on X 2025-07-16 21:06:04 UTC 19.5K followers, 18.2K engagements
"$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO" @RNAiAnalyst on X 2025-07-14 08:43:34 UTC 19.5K followers, 5052 engagements
"@GeneInvesting 'good day for gene therapy'.seriously $SRPT just dropped their gene therapy pipeline except for X LGMD type cause of PRV. :)" @RNAiAnalyst on X 2025-07-17 13:58:06 UTC 19.5K followers, XXX engagements
"Hormone Replacement Therapy.one of @drmakaryFDA's favorite health interventions. Any playable stocks in that regard" @RNAiAnalyst on X 2025-07-14 21:12:14 UTC 19.5K followers, 5068 engagements
"I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)" @RNAiAnalyst on X 2025-07-17 18:21:28 UTC 19.5K followers, 2217 engagements
"$ARWR bought some after-hours for giggles. $SRPT" @RNAiAnalyst on X 2025-07-16 20:22:37 UTC 19.5K followers, 2959 engagements
"$apge priced for perfection or near that with $2.8B market cap on eve of critical atopic derm read-out. Science risk seems low but then again why are they first in category Also pin action on $nktr of interest" @RNAiAnalyst on X 2025-07-07 06:13:27 UTC 19.5K followers, 4978 engagements
"I never considered $MREO because I didn't like their AATD program but $470M market cap and $60M in cash.what am I missing $RARE" @RNAiAnalyst on X 2025-07-09 20:47:41 UTC 19.5K followers, 5880 engagements
"$MGX Old enough remember a time when investing in biotechs trading XX% below cash was viewed as irresponsible. .even partner $IONS didn't want the free cash an acquisition would have gotten them. 🚀🚀" @RNAiAnalyst on X 2025-07-09 18:15:30 UTC 19.5K followers, 3273 engagements
"$apge: ' we are accelerating development plan by running another higher dose trial'. Mmh yep 'accelerating' by taking another year before arriving at p3 dose" @RNAiAnalyst on X 2025-07-07 12:14:08 UTC 19.5K followers, 4217 engagements
"$srpt been traveling but aren't they due to report limb girdle data Too busy with salvaging Elevidys and keeping company liquid" @RNAiAnalyst on X 2025-07-03 10:39:36 UTC 19.5K followers, 3484 engagements
"@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR" @RNAiAnalyst on X 2025-07-07 11:10:26 UTC 19.4K followers, XXX engagements
"HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN" @RNAiAnalyst on X 2025-07-14 10:32:31 UTC 19.5K followers, 8715 engagements
"$SRPT does restructuring largely take bankruptcy risk off table.assuming no more Elevidys safety surprises + exon skippers staying on market" @RNAiAnalyst on X 2025-07-17 07:35:12 UTC 19.5K followers, 2293 engagements
"I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA" @RNAiAnalyst on X 2025-07-07 21:42:55 UTC 19.5K followers, 2413 engagements
"$mgx trading 2/3 below healthy cash balance. When will a shareholder go activist and ask them to slow-walk hemophilia program while looking for an alternative exit for its potentially lucrative small-sized CRISPR proteins. $IONS" @RNAiAnalyst on X 2025-07-03 13:44:38 UTC 19.5K followers, 3732 engagements
"$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa" @RNAiAnalyst on X 2025-07-11 09:44:26 UTC 19.5K followers, 6338 engagements
"A XX minute heads-up. Sounds serious. $SRPT" @RNAiAnalyst on X 2025-07-16 20:10:53 UTC 19.5K followers, 4653 engagements
"@Franca_ole @BehaviorFin The big issue with essentially all large gene replacement tools is that they require DNA/AAV templates for delivery. $SGMO $PRME $MGX" @RNAiAnalyst on X 2025-07-11 10:18:16 UTC 19.5K followers, XXX engagements
"$KALV oral on-demand pill for HAE approved by FDA $APGE anti-IL13 p2 hits in atopic dermatitis $JSPR CS Urticaria drug efficacious but manufacturing issues Quite the morning in the #dermatology space" @RNAiAnalyst on X 2025-07-07 13:08:59 UTC 19.5K followers, 5632 engagements
"$srpt been out all day but -X% suggests it's kneejerk to $capr CRL and #FDA not believing in medicines for DMD" @RNAiAnalyst on X 2025-07-11 17:46:40 UTC 19.5K followers, 4083 engagements
"Get ready for some volatility as Trump gets ready to fire #Fed chair Powell. Ultimately would be very positive for #biotech. Could be a great buying op" @RNAiAnalyst on X 2025-07-16 15:56:44 UTC 19.5K followers, 2083 engagements
"On the X hand #FDA said it wants to promote #wearables enabling people access to their health info👏. On the other hand it is now threatening to take action against a blood pressure wearable maker for not having it licensed as a medical device. wtf" @RNAiAnalyst on X 2025-07-17 07:29:50 UTC 19.5K followers, 1826 engagements
"@GeneInvesting especially the impressive subQ data for CNS. platform. $srpt $arwr" @RNAiAnalyst on X 2025-07-17 11:36:08 UTC 19.5K followers, XXX engagements
"$APGE clearly efficacious though pbo response on high end. On safety XX% non-infective #conjunctivitis taking median of XX days to resolve. I'll trade that in for an ISR any day -- $NKTR" @RNAiAnalyst on X 2025-07-07 10:53:57 UTC 19.5K followers, 16.7K engagements
"$KALV 50k on-demand treatments per year.pill option should grow usage say 60k EKTERLY stands out: oral rapid response clean safety -- only insurance will limit market share XX% market share-- $600M rev MC: $760M well financed Expect solid profits in '26 PT: $25" @RNAiAnalyst on X 2025-07-08 16:49:07 UTC 19.5K followers, 2432 engagements
"Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB" @RNAiAnalyst on X 2025-07-09 11:52:12 UTC 19.5K followers, 2901 engagements
"$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA" @RNAiAnalyst on X 2025-06-17 12:16:22 UTC 19.5K followers, 2917 engagements